Yannick Foerster

7PUBLICATIONS
11CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMicroelectromechanical systems (MEMS)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 17, 2026
Sirolimus for Secondary Prevention of Cutaneous Squamous Cell Carcinoma in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Yannick Foerster, Julia Palaras, Kristine Mayer

|Dec 08, 2025
High ROR1 Expression Is Associated With Poor Differentiation and Perineural Invasion in Cutaneous Squamous Cell Carcinoma.

Yannick Foerster, Kristine E Mayer, Tilo Biedermann

|Aug 25, 2025
Multimodal Approach Predicts Relapse upon Cessation of Immune Checkpoint Inhibitors in Advanced Melanoma.

Ka-Won Noh, Yuri Tolkach, Doris Helbig

|Aug 19, 2025
Interventions for Bowen's disease: A systematic review and network meta-analysis of randomized controlled trials.

Yannick Foerster, Kristine Mayer, Marta Dechant

|Apr 04, 2025
Survival after cessation of immunotherapies in melanoma: A systematic review and meta-analysis.

Kristine E Mayer, Lydia Warburton, Anne Zaremba

|Feb 11, 2025
Elevated Neutrophil-to-Lymphocyte Ratio Correlates With Liver Metastases and Poor Immunotherapy Response in Stage IV Melanoma.

Yannick Foerster, Kristine Mayer, Sophia Wasserer

Pageof 2

Frequent Collaborators

5 joint publications

Oana-Diana Persa

4 joint publications

Kristine Mayer

2 joint publications

Tilo Biedermann

1 joint publications

Sarah Preis